Verdict: KEEP | LR 1.2 (mild bullish)

SNPS is the stronger half of the EDA duopoly, mid-integration of a transformational $35B acquisition, trading at a cyclical trough (13% of 52-week range, RSI 31) on identifiable headwinds — all partially priced. Not a filtration candidate, though conviction is moderate. The negative trailing alpha (-19.6%) is real and SNPS-specific, but it traces to backward-looking drivers. The forward picture — Ansys integration, backlog conversion, Q2 earnings — is more constructive than what the price reflects.

This is not an alpha call. This is a "don't remove a franchise business trading at trough valuation" hold.

Factor Decomposition

The CDNS comparison is the critical detail. Same duopoly, same macro, same China/BIS exposure — yet SNPS underperforms by 17 percentage points over one year. The gap is entirely SNPS-specific: Ansys acquisition overhang, Design IP segment decline, and BIS subpoenas. CDNS has none of these.

The negative MTUM beta (-1.58) tells us who's selling: momentum and systematic funds. Short interest is only 2.5% — no crowded short thesis. The selling is mechanical, not fundamental. That's the setup for a mean-reversion trade, not a reason to remove from the basket.

GAAP Reality Check

Management quotes a "42% adjusted operating margin." The bridge to GAAP tells a different story.

Q1 FY2026 operating income reconciliation (10-Q):

The Ansys acquisition created $14.2B in gross intangible assets that amortize at $1.4-1.6B/year through at least 2031. This isn't one-time. It's a decade of GAAP drag. The amortization schedule: $1.21B remainder FY2026, $1.55B FY2027, $1.39B FY2028, $1.38B/year through FY2030, $5.39B thereafter.

SBC runs $1.0B/year with 633K shares issued per quarter. Share count jumped 23% (154M to 191M diluted) from the Ansys deal plus ongoing dilution.

Interest expense: $163M/quarter ($651M annualized) on $10B fixed-rate Senior Notes at 4.55-5.70%. That's 19% of operating cash flow going to debt service.

Including SBC but excluding intangible amortization and restructuring, operating margin is 31.3% — solid for a software/IP business, but materially different from the 42% headline.

GAAP operating income actually declined 19% year-over-year ($203M vs $252M) despite revenue growing 66%. That's the Ansys integration cost in one number.

What's Working

Ansys integration is beating expectations. The Ansys contribution runs at $3.54B annualized — well above prior estimates of $2.5B. Design Automation adjusted operating margin expanded to 47% from 40%. The 83% of revenue that isn't Design IP is performing.

Cash generation is exceptional. $857M operating cash flow in Q1 alone, annualizing to ≈$3.4B. The company repaid the entire $3.5B term loan in Q1. Debt now sits at $10B Senior Notes at fixed rates — high but serviceable at this cash flow level.

Backlog provides revenue visibility. $11.3B total, with $5.3B (47%) recognizable in the next 12 months. For context, FY2026 revenue guidance is $9.56-9.66B. The contracted pipeline covers roughly half of full-year guidance before any new bookings.

Capital return signals management confidence. $250M accelerated share repurchase initiated March 2, 2026 (8-K), part of a new $2B authorization approved February 2026. At current prices, that's modest relative to $77B market cap, but the timing — near 52-week lows — is a confidence signal.

AI is a tailwind, not a threat. V-Score 4.03. Sign-off tools (PrimeTime, StarRC, IC Validator) are de facto industry standards — foundries won't accept tape-outs without them. These require foundry-specific PDK calibration data from decades of co-development, inaccessible to any AI model. AlphaChip addresses one sub-step (floorplanning) and is 640x slower than commercial tools per UC San Diego replication. NVIDIA invested $2B in strategic partnership (December 2025). AI increases chip complexity, which increases EDA demand.

What's Broken

Design IP is in structural decline. Revenue fell 6.5% YoY ($407M vs $435M). Adjusted operating margin collapsed from 29% to 16% in one year — nearly halved. Management admitted "certain roadmap and resource decisions that did not yield their intended results." They're divesting the Processor IP business to GlobalFoundries (signed January 2026, closing H2 2026). The segment is now 17% of total revenue, down from ≈30% a year ago.

Management guides "muted FY2026 growth" for Design IP — which, given Q1's -6.5%, reads as "still contracting." The worldview prediction for Design IP returning to positive YoY growth by Q4 FY2026 has been lowered to 40%.

This matters less at 17% of revenue than it did at 30%. But the margin compression (29% to 16%) means Design IP is barely profitable on an adjusted basis and likely unprofitable on a GAAP basis after allocation. Management is pivoting resources to "highest-growth opportunities" — the right move, but execution takes time.

BIS subpoenas create open-ended regulatory risk. The Q1 10-Q discloses administrative subpoenas from BIS "requesting production of information and documentation relating to transactions with certain Chinese entities." Additionally, BIS has implemented new controls on "ECAD software for advanced semiconductor packaging involving multiple chips or chiplets." Prior ECAD controls were imposed in Q3 2025, rescinded, and may continue to impact business.

China revenue is ≈10% at the current exit rate and declining. The risk isn't the current revenue — it's an enforcement action or fine. BIS subpoenas are Tier 1 legal evidence. We don't know the scope, the timeline, or the potential outcome. This is genuine uncertainty, not a quantifiable risk.

The Ansys acquisition creates multi-year headwinds. Beyond the GAAP impacts detailed above: restructuring charges of $300-350M (largest in SNPS history, $118M taken in Q1, majority in FY2026). This is a business being fundamentally reorganized — involuntary terminations across the combined entity, segment reallocation, asset divestitures. Integration of a $35B acquisition is a multi-year project. Q1 results suggest execution is on track, but one quarter doesn't validate a multi-year thesis.

15-Week Outlook

Catalysts within window:

• Q2 FY2026 earnings on May 27. Backlog should convert. If Ansys integration continues and Design IP shows sequential stabilization vs Q1, sentiment improves. Consensus expects $3.15 EPS.
• ASR completion by June 1.
• Potential BIS subpoena developments (timing unknown — could be within window or well beyond).

Base case (60%): Stock stabilizes in the $380-430 range. Q2 earnings confirm the integration thesis. Design IP is flat to slightly better sequentially. No BIS escalation. Modest outperformance vs QQQ as oversold conditions normalize. Roughly inline to +5% relative over 15 weeks.

Bull case (20%): Q2 earnings beat on Ansys upside. Design IP shows signs of stabilization. Broad tech rotation back into quality names at trough valuations. +10-15% relative.

Bear case (20%): BIS enforcement action or escalation. Design IP deterioration accelerates. Broader semi/tech selloff amplified by 1.36 beta. Or simply: negative momentum persists. -5% to -15% relative.

Expected relative return: Roughly +2% to +3% vs QQQ over 15 weeks, weighted by scenarios. Positive but not large.

Edge Assessment

Do we have edge? Barely. At $77B market cap with 22 analyst coverage, the informational asymmetry is thin. The market knows about Design IP weakness, BIS subpoenas, and Ansys integration costs — these are all in public filings and the earnings call. Our edge, such as it is, comes from the filtration framework itself: we're asking "is this among the worst 10-15 of 50 names?" rather than "is this stock mispriced?" The answer to the former is clearly no. SNPS has real problems but also exceptional structural quality that puts it firmly in the upper half of the working set.

Counterparty: Momentum/systematic funds are selling (MTUM beta -1.58, price below both MAs). This is trend-following, not fundamental reassessment. The counterparty doesn't care about the $11.3B backlog or the Ansys run rate — they care about the price chart.

What would flip to REMOVE:

• BIS enforcement action (not just subpoenas — an actual penalty or business restriction)
• Ansys customer retention falls below 80% NRR
• Design IP revenue decline accelerates beyond -10% YoY
• Q2 earnings miss driven by backlog non-conversion